Shuttle Pharmaceuticals Holdings (SHPH) Interest Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $12122.0 for Q1 2026.

• In Q1 2026, Interest Expenses rose 124.69% year-over-year to $12122.0; the TTM figure through Mar 2026 stood at -$19660.0 (up 97.39% YoY), while the FY2025 annual figure was $8730.0, changed 0.44% from the prior year.
• Interest Expenses was $12122.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$35117.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $729351.0 in Q2 2023 to a low of -$1.2 million in Q4 2024.
• Historically, Interest Expenses has averaged $149241.6 across 5 years, with a median of $13725.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 19231.46% in 2023, then plunged 323.67% in 2024.
• A 5-year view of Interest Expenses shows it stood at -$2781.0 in 2022, then soared by 19231.46% to $532046.0 in 2023, then slumped by 323.67% to -$1.2 million in 2024, then surged by 97.05% to -$35117.0 in 2025, then soared by 134.52% to $12122.0 in 2026.
• The last three Interest Expenses figures came in at $12122.0 (Q1 2026), -$35117.0 (Q4 2025), and $721.0 (Q3 2025), per Business Quant data.